Close Menu

stock offering

NEW YORK (GenomeWeb) – WaferGen Biosystems has filed with regulators to offer up to $40 million of its common stock.

NEW YORK (GenomeWeb News) – Foundation Medicine disclosed after the close of the market on Tuesday that it has filed a request with the US Securities and Exchange Commission to withdraw a proposed public offering of

NEW YORK (GenomeWeb News) – Microarray-based diagnostics firm SQI Diagnostics today announced it raised gross proceeds of C$4.2 million (US$3.8 million) in a public offering.

NEW YORK (GenomeWeb News) – Exact Sciences has raised $137.7 million in net proceeds from a public offering of 11.5 million shares of common stock.

NEW YORK (GenomeWeb News) – Exact Sciences today priced its common stock offering of 10 million shares at $12.75 per share.

NEW YORK (GenomeWeb News) – Venaxis today priced the public offering of about 8.3 million shares of its common stock at $2.40 per share.

NEW YORK (GenomeWeb News) – Exact Sciences said after the close of the market Wednesday that it has launched a $125 million public offering of common stock.
The Madison, Wis.-based molecular diagnostics developer didn't say how many shares it intends to offer.

NEW YORK (GenomeWeb News) – BG Medicine today priced a public offering of common stock that is anticipated to bring in $8.9 million in net proceeds.

NEW YORK (GenomeWeb News) – Foundation Medicine has filed with the US Securities and Exchange Commission to sell up to $150 million of its common stock in a public offering.

NEW YORK (GenomeWeb News) – Nanosphere announced after the close of the market on Tuesday an agreement to sell up to $30 million of shares of its common stock to investment fund Aspire Capital.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.